Pre-Market Analysis on STSI, IPXL, PCYC, and UTHR
Today 10:55 EDT
from ACCESSWIRE
A new class of anti-cancer drugs that allow the immune system to attack cancer cells are generating considerable excitement among patients, doctors, and investors. New results being released ahead of... Read More
from Forbes Real Time
Benzinga's Top Upgrades
May 13, 2013
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
category
Pharmaceuticals
from Trefis
Six Superstars for Your Biotech Portfolio: John McCamant Source: Tracy Salcedo-Chourr? of The Life Sciences Report (5/9/13) http://www.thelifesciencesreport.com/pub/na/15256 We are in the “golden age,”... Read More
from Bio-Wire.Com
Bull’s Eye Report: Amgen (AMGN)
May 09, 2013
Bull’s Eye Report: Pharmacyclics (PCYC)
May 07, 2013
Goldman Sachs Starts Pharmacyclics (PCYC) at Neutral
May 07, 2013
Three Top Performing Healthcare Stocks to Watch
May 06, 2013
category
Pharmaceuticals
,
Industrials
from Trefis
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential Source: George S. Mack of The Life Sciences Report (5/2/13) http://www.thelifesciencesreport.com/pub/na/15211 In January 2013, The... Read More
from Bio-Wire.Com
Pharmacyclics Reports First Quarter 2013 Results
May 01, 2013
from PR Newswire
Short Sellers Move into Celgene, Regeneron
April 26, 2013
Bull’s Eye Report: Polycyclics (PCYC)
April 26, 2013
Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
April 24, 2013
from PR Newswire
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Pharmacyclics, Inc. (PCYC) was identified as having a larger market cap than the smaller end of the S&P... Read More
category
Stocks
from Market News Video
Stocks To Watch For April 23, 2013
April 22, 2013
( click to enlarge ) Pharmacyclics, Inc. (NASDAQ:PCYC) had a nice breakout today with a pop of $4.17 to 81.69 or 5.38% on 959K shares, the biggest volume in a couple weeks. The heavy buying makes this... Read More
from DailyMarkets.com
Stocks to Watch for April 23, 2013
April 22, 2013
from AC Investor Blog
(PCYC) Pharmacyclics Earns 4th Milestone
April 21, 2013
Pharmacyclics, Inc. (PCYC) recently announced the enrollment of the fifth patient in a phase III... Visit StockBlogHub to view complete post. Read More
from Stock Blog Hub
9 Technical Setups for the Week Ahead
April 20, 2013
from AC Investor Blog
from PR Newswire
Amarin, Pharmacyclics, Anthera Pharma, Star Scientific, and Impax Laboratories Under StockCall's Microscope
April 16, 2013
from PR Newswire
Lower Prices Ahead
April 16, 2013
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here